All stock lists
MapLight Therapeutics, Inc. (MPLT)
NASDAQ: MPLT · Real-Time Price · USD
Healthcare · Biotechnology
7.90-0.07 (-0.88%)
Insider Score
––Not scored
MPLT Insider Score
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
MPLT Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 |
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Revenue Growth (YoY) | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — |
| Gross Profit | — | — | — | — | — |
| SG&A Expense | 10.11 M | 10.82 M | 18.75 M | 4.40 M | — |
| R&D Expense | 53.44 M | 53.68 M | 64.62 M | 27.09 M | 26.85 M |
| Operating Expenses | 63.55 M | 64.50 M | 83.38 M | 31.50 M | 30.66 M |
| Operating Income | -63.55 M | -64.50 M | -83.38 M | -31.50 M | -30.66 M |
| Pretax Income | -60.19 M | -60.67 M | -79.55 M | -29.42 M | -29.84 M |
| Tax Provision | — | — | — | — | — |
| Net Income | -60.19 M | -60.67 M | -79.55 M | -29.42 M | -29.84 M |
| EPS (Basic) | -1.32 | -1.34 | -2.47 | -0.71 | -0.72 |
| EPS (Diluted) | -1.32 | -1.34 | -2.47 | -0.71 | -0.72 |
| Shares Outstanding | 45.43 M | 45.21 M | 32.15 M | 41.43 M | 41.43 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.